Invention Grant
- Patent Title: Pyridyl reverse sulfonamides for HBV treatment
-
Application No.: US14957008Application Date: 2015-12-02
-
Publication No.: US09765050B2Publication Date: 2017-09-19
- Inventor: Ryan C. Clark , Yen Truong , Nicholas Stock , Jason Jacintho
- Applicant: NOVIRA THERAPEUTICS, INC.
- Applicant Address: US PA Doylestown
- Assignee: NOVIRA THERAPEUTICS, INC.
- Current Assignee: NOVIRA THERAPEUTICS, INC.
- Current Assignee Address: US PA Doylestown
- Agency: Lathrop & Gage LLP
- Agent Brian C. Trinique
- Main IPC: A61K45/06
- IPC: A61K45/06 ; A61K31/415 ; C07D333/26 ; C07D213/81 ; C07D231/18 ; A61K31/44 ; A61K31/381
Abstract:
The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
Public/Granted literature
- US20160185748A1 PYRIDYL REVERSE SULFONAMIDES FOR HBV TREATMENT Public/Granted day:2016-06-30
Information query
